Time from drug approval to reimbursement longer in U.S. than some european countries
Time from approval to reimbursement of new drugs varies between countries and is shortest in Switzerland and Germany, both of ...
Time from approval to reimbursement of new drugs varies between countries and is shortest in Switzerland and Germany, both of ...
Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended on our ...
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase ...
Eli Lilly said Tuesday that it will start providing low-dose vials of its obesity drug Zepbound through its direct-to-consumer platform, ...
The longest clinical trial to date for a blockbuster Eli Lilly metabolic disorder drug now has data showing the treatment ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign ...
WASHINGTON — Democrats have set the stage for a convention this week packed with boasts about some of their most ...
Mutated variants of a particular ion channel cause difficult-to-treat epilepsy. A study published in the journal Nature now shows that ...
Eisai’s efforts to bring its FDA-approved Alzheimer’s disease drug to patients in Europe have hit a setback. A European Medicines ...
LONDON — European regulators on Friday said that an Alzheimer’s therapy from Eisai and Biogen should be rejected, again diverging ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.